Updated:
CL Management Group
CL Management Group was established as the private investment vehicle for the Li family, whose wealth originates from the creation and subsequent sale of...
CL Management Group
CL Management Group was established as the private investment vehicle for the Li family, whose wealth originates from the creation and subsequent sale of a leading clinical research organization. The family office is structured to manage the entirety of the family's financial assets, operating with a lean internal team that handles direct investments, asset allocation, and philanthropic activities. The office's founding principals maintain a low public profile, directing investments from a base in the United States. The office engages in a flexible, multi-asset class strategy spanning venture capital, growth equity, public equities, and real assets. Its venture investments have historically concentrated on technology and life sciences, with confirmed positions including a notable early stake in the fintech infrastructure provider Plaid. The public securities portfolio is managed with a value-oriented, concentrated approach, taking meaningful positions in companies where the team develops high-conviction views. Geographic focus remains predominantly North American, with opportunistic exposure to select Asian markets. With no external limited partners, CL Management Group does not report assets under management. The team size, while undisclosed, is understood to be small, reflecting a highly centralized investment process led by family principals. The office is not known to participate in fund commitments or club deals, preferring direct control over its positions. In recent years, the principals have deepened their focus on mission-aligned investments, intertwining financial returns with social impact through direct venture engagements and grant-making from the family's private foundation. A core structural differentiator for CL Management Group is its origin in operating a complex, regulated healthcare services company. This background provides the office with a distinct lens for evaluating venture-stage life science and enterprise technology businesses—assessing them from the perspective of a builder rather than a financial allocator. The absence of a fundraising cycle allows the office to underwrite multi-decade holding periods that outlast typical fund lifetimes, a posture few professional investors can match.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
—
Corporate office
—
Frequently asked questions
What is the origin of the wealth managed by CL Management Group?
The wealth managed by CL Management Group stems from the founding and sale of a prominent clinical research organization by the Li family. The successful exit of this healthcare technology enterprise created the core capital base now stewarded by the family office, with a mandate for long-term preservation and selective growth across asset classes.
Does CL Management Group accept external capital or function as a fund manager?
No. CL Management Group operates exclusively as a single-family office. It does not manage outside capital, sponsor commingled funds, or accept co-investors alongside its direct deals. All investment activity is funded solely by the Li family's own assets, granting the office permanent capital and a flexible, patient mandate.
What is the office's approach to direct venture investing?
CL Management Group typically participates in direct venture rounds for technology and life sciences companies, often entering at early or growth stages. The office leverages the family's operational background in healthcare technology to evaluate clinical and enterprise-focused startups. It is known to hold positions for extended periods without pressure to exit on venture capital fund timelines.
How does the family's operating background influence the investment strategy?
Having built and sold a large clinical research organization, the Li principals bring an operator's perspective to investment decisions. This manifests in a preference for companies that solve complex, regulated problems and in a willingness to engage strategically with portfolio company management. The experience provides a differentiated lens for assessing scale and durability in healthcare and enterprise technology markets.
Does CL Management Group disclose its assets under management or team size?
No. As a private single-family office with no regulatory requirement to file public disclosures, CL Management Group does not publish any information about its assets under management, portfolio composition, or staff headcount. All such figures remain confidential.
What philanthropic activities are associated with CL Management Group?
The Li family maintains a private philanthropic foundation that is structured separately from the investment office. The foundation directs grant-making toward social impact causes, often aligned with the healthcare and technology themes central to the family's wealth creation. This separation preserves the integrity of the investment process while allowing for mission-driven capital deployment.
What distinguishes CL Management Group's investment horizon from a traditional venture capital firm?
The office operates with permanent, proprietary capital and no limited-partner redemption pressures. This allows CL Management Group to underwrite holding periods that can extend well beyond a typical ten-year venture fund cycle, sometimes spanning multiple decades. The structure eliminates the need to sell assets to generate distributions, enabling truly patient capital.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: